BV-AVD-R Treatment Children Hodgkin's Lymphoma
Phase 2 Unknown
44 enrolled
Zanubrutinib Combined With R-CHOP Regimen in the Treatment of Newly Diagnosed DLBCL With High-risk Factors
Phase 2 Unknown
30 enrolled
Modified BFM-95 Regimen as First-Line Chemotherapy in Adults With T- Lymphoblastic Lymphoma
Phase 2 Unknown
50 enrolled
Irinotecan and Temozolomide for Ewing Sarcoma
Phase 2 Unknown
60 enrolled
ZR2-CHOP
Phase 2 Unknown
36 enrolled
DLCL002 Protocol for Patients With High Risk Aggressive B-cell Lymphoma
Phase 2 Unknown
118 enrolled
Treatment of Mature B-ALL and Burkitt Lymphoma (BL) in Adult Patients. BURKIMAB-14.
Phase 2 Unknown
100 enrolled
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Phase 2 Unknown
318 enrolled 9 charts
LYTPET
Phase 2 Unknown
150 enrolled
Biomarker Guided Treatment in DLBCL
Phase 2 Unknown
128 enrolled
Compare Efficacy of CHOP Versus Fractionated ICED in Transplant-eligible Patients With Previously Untreated PTCL
Phase 2 Unknown
134 enrolled
PEG-ASP+Gemoxd vs. PEG-ASP+CHOP as First-line Chemotherapy to Treatment NK/T-cell Lymphoma With Early Stage
Phase 2 Unknown
100 enrolled
Trial of DA-EPOCH Regimen for NHL With HLH
Phase 2 Unknown
50 enrolled
Chidamide Combined With CHOPE Regimen for Peripheral T-cell Lymphoma Patients
Phase 2 Unknown
114 enrolled
CHEMO-T
Phase 2 Unknown
87 enrolled
Chidamide Plus R-CHOP in Elderly DLBCL
Phase 2 Unknown
49 enrolled
Modified MRCUKALLâ…«/ECOGE2993 Regimen for ALL
Phase 2 Unknown
100 enrolled
Phase II Prospective Trial of Addition of Rituximab to Reduced Dose CHOP Chemotherapy in DLBC L Patients Aged 65 Years and Over
Phase 2 Unknown
57 enrolled
Efficacy Study of Lucentis in the Treatment of Retinoblastoma
Phase 2 Unknown
20 enrolled
Combination Chemotherapy in Treating Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Phase 2 Unknown
180 enrolled
Combination Chemotherapy Plus Rituximab in Treating Patients With Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma
Phase 2 Unknown
Safety and Efficacy of an Adult Acute Lymphoblastic Leukemia Chemotherapy for Adult Lymphoblastic Lymphoma
Phase 2 Unknown
155 enrolled
Combination Chemotherapy in Treating Patients With Hodgkin's Disease and HIV Infection
Phase 2 Unknown
30 enrolled
Combination Chemotherapy With or Without Radiation Therapy in Treating Children With Brain Tumors
Phase 2 Unknown
50 enrolled
Combination Chemotherapy in Treating Adults With Acute Lymphocytic Leukemia
Phase 2 Unknown
Radiation Therapy and Combination Chemotherapy in Treating Young Patients With Metastatic Medulloblastoma Who Have Undergone Surgery
Phase 2 Unknown
29 enrolled
Topotecan, Vincristine, and Doxorubicin in Treating Young Patients With Refractory Stage 4 Neuroblastoma
Phase 2 Unknown
63 enrolled
High-Dose Chemotherapy Given Together With Peripheral Blood Stem Cell Transplant in Treating Patients With Intestinal T-Cell Lymphoma
Phase 2 Unknown
60 enrolled
Combination Chemotherapy and Rituximab in Treating Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma
Phase 2 Unknown
150 enrolled
Vincristine, Dactinomycin, and Cyclophosphamide in Treating Patients With Embryonal Rhabdomyosarcoma
Phase 2 Unknown
41 enrolled
Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Embryonal Rhabdomyosarcoma
Phase 2 Unknown
32 enrolled
Chemotherapy and Surgery Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Neuroblastoma
Phase 2 Unknown
Combination Chemotherapy With or Without Radiation Therapy and Peripheral Stem Cell Transplant in Treating Children With Hodgkin's Lymphoma
Phase 2 Unknown
260 enrolled
Chemotherapy Followed by Surgery and Radiation Therapy With or Without Stem Cell Transplant in Treating Patients With Relapsed or Refractory Wilms' Tumor or Clear Cell Sarcoma of the Kidney
Phase 2 Unknown
75 enrolled
Radiation Therapy Followed By Combination Chemotherapy in Treating Young Patients With Supratentorial Primitive Neuroectodermal Tumors
Phase 2 Unknown
30 enrolled
GM-CSF, Rituximab, and Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Follicular Non-Hodgkin Lymphoma
Phase 2 Unknown
30 enrolled
Temozolomide, Nedaplatin, Vincristine, and Radiotherapy as First-line Treatment in Newly Diagnosed Primary CNS Lymphoma
Phase 2 Unknown
16 enrolled
Study With Rituximab, Cyclophosphamide, Doxorubicin Liposomal (Myocet®), Vincristine, Prednisone, (R-COMP) to Treat Non-Hodgkin's Lymphoma
Phase 2 Unknown
50 enrolled
HD-MCL2003
Phase 2 Unknown
20 enrolled
Applying Pediatric Regimens to Younger Adult Patients With Acute Lymphoblastic Leukemia (ALL)
Phase 2 Unknown
120 enrolled
Study Comparing Imatinib With Chemotherapy as Induction in Elderly Patients With Philadelphia Positive Acute Lymphoblastic Leukemia (ALL)
Phase 2 Unknown
A Dose Study of Doxil in a Dose Dense, 14 Day CDOP/Rituximab Regimen for Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma (NHL)> 60 Years or With Compromised Cardiac Status.
Phase 2 Unknown
27 enrolled